Neo Ivy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thor Industries
THO
|
+$3.92M |
| 2 |
Lockheed Martin
LMT
|
+$3.9M |
| 3 |
AvalonBay Communities
AVB
|
+$3.89M |
| 4 |
Ferguson
FERG
|
+$3.45M |
| 5 |
CarMax
KMX
|
+$3.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$3.46M |
| 2 |
CVS Health
CVS
|
+$3.23M |
| 3 |
Accenture
ACN
|
+$3.19M |
| 4 |
Salesforce
CRM
|
+$3.15M |
| 5 |
FedEx
FDX
|
+$3.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.34% |
| 2 | Industrials | 17.28% |
| 3 | Technology | 13.9% |
| 4 | Financials | 8.39% |
| 5 | Consumer Staples | 7.42% |
Similar funds
Neo Ivy Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Neo Ivy Capital Management held 490 positions worth $228M, up 20% from $190M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Neo Ivy Capital Management deployed $53.7M of net new capital in Q3 2023, opening 212 new positions and adding to 57 existing holdings. Its largest new stake was Lockheed Martin: 8,796 shares worth $3.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 10% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was CVS Health, an estimated $3.23M trimmed.
- Neo Ivy Capital Management's largest Q3 2023 buy was Lockheed Martin: 8,796 shares worth $3.6M.
- Neo Ivy Capital Management added most to Thor Industries in Q3 2023, an estimated $3.92M increase.
- Neo Ivy Capital Management's biggest Q3 2023 reduction was CVS Health, cutting an estimated $3.23M.
- Neo Ivy Capital Management fully exited Humana in Q3 2023, selling an estimated $3.46M.
- Neo Ivy Capital Management's ten largest holdings make up 16% of its $228M portfolio in Q3 2023.
- Neo Ivy Capital Management opened 212 new positions and closed 183 in Q3 2023.
- Neo Ivy Capital Management's portfolio value rose 20% quarter-over-quarter to $228M.
Based on Neo Ivy Capital Management's 13F filing for Q3 2023, filed 30 Nov 2023.